Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSYK
āļāļ·āđāļāļāļĢāļīāļĐāļąāļStryker Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMar 17, 1980
āļāļĩāļāļĩāđāļLobo (Kevin A)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ53000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMar 17
āļāļĩāđāļāļĒāļđāđ1941 Stryker Way
āđāļĄāļ·āļāļPORTAGE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ49002
āđāļāļĢāļĻāļąāļāļāđ12693852600
āđāļ§āđāļāđāļāļāđhttps://www.stryker.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSYK
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMar 17, 1980
āļāļĩāļāļĩāđāļLobo (Kevin A)
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
Ms. Ronda E. Stryker
Independent Director
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
Ms. Mary K. Brainerd
Independent Director
Mr. Rajeev Suri
Independent Director
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
Ms. Ronda E. Stryker
Independent Director
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
Jensen Quality Growth ETF
iShares U.S. Medical Devices ETF
AdvisorShares Focused Equity ETF
Gabelli Growth Innovators ETF
Global X Aging Population ETF
Knowledge Leaders Developed World ETF
Health Care Select Sector SPDR Fund
Proshares Ultra Health Care
iShares U.S. Healthcare ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Jensen Quality Growth ETF
āļŠāļąāļāļŠāđāļ§āļ6.01%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ4.17%
AdvisorShares Focused Equity ETF
āļŠāļąāļāļŠāđāļ§āļ3.62%
Gabelli Growth Innovators ETF
Global X Aging Population ETF
āļŠāļąāļāļŠāđāļ§āļ2.85%
Hennessy Sustainable ETF
āļŠāļąāļāļŠāđāļ§āļ2.77%
Knowledge Leaders Developed World ETF
āļŠāļąāļāļŠāđāļ§āļ2.73%
Health Care Select Sector SPDR Fund
āļŠāļąāļāļŠāđāļ§āļ2.51%
Proshares Ultra Health Care
āļŠāļąāļāļŠāđāļ§āļ2.42%
iShares U.S. Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ2.4%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
4.36B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
SYK.NB Interim Cash Dividend of gross USD 0.88 paid on Apr 30, 2026 going ex on Mar 31, 2026
SYK.NB Final Cash Dividend of gross USD 0.88 paid on Jan 30, 2026 going ex on Dec 31, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ